Barclays Issues Positive Forecast for Keurig Dr Pepper (NASDAQ:KDP) Stock Price

Keurig Dr Pepper (NASDAQ:KDP) had its target price lifted by analysts at Barclays from $37.00 to $38.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm currently has an “overweight” rating on the stock. Barclays‘s target price would suggest a potential upside of 11.65% from the stock’s current price.

Several other research analysts also recently issued reports on the stock. Hsbc Global Res upgraded shares of Keurig Dr Pepper from a “hold” rating to a “strong-buy” rating in a report on Friday. JPMorgan Chase & Co. increased their price target on Keurig Dr Pepper from $37.00 to $40.00 and gave the stock an “overweight” rating in a report on Wednesday, February 26th. Argus started coverage on shares of Keurig Dr Pepper in a research note on Wednesday, April 16th. They set a “buy” rating and a $40.00 target price on the stock. Piper Sandler raised shares of Keurig Dr Pepper from a “neutral” rating to an “overweight” rating and raised their price objective for the company from $35.00 to $40.00 in a research note on Wednesday, April 9th. Finally, HSBC raised shares of Keurig Dr Pepper from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $36.00 to $42.00 in a report on Friday. Four equities research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $39.33.

Keurig Dr Pepper Stock Performance

KDP stock traded down $0.37 during mid-day trading on Monday, hitting $34.03. 1,236,560 shares of the company were exchanged, compared to its average volume of 9,990,199. The stock has a market capitalization of $46.18 billion, a PE ratio of 20.63, a price-to-earnings-growth ratio of 2.42 and a beta of 0.54. The business has a 50 day simple moving average of $34.13 and a 200-day simple moving average of $33.18. The company has a current ratio of 0.53, a quick ratio of 0.36 and a debt-to-equity ratio of 0.50. Keurig Dr Pepper has a 1-year low of $30.12 and a 1-year high of $38.28.

Keurig Dr Pepper (NASDAQ:KDP) last announced its earnings results on Thursday, April 24th. The company reported $0.42 EPS for the quarter, topping the consensus estimate of $0.38 by $0.04. The company had revenue of $3.64 billion for the quarter, compared to analysts’ expectations of $3.57 billion. Keurig Dr Pepper had a net margin of 15.04% and a return on equity of 10.45%. On average, equities analysts forecast that Keurig Dr Pepper will post 1.92 earnings per share for the current year.

Insider Activity

In other Keurig Dr Pepper news, Chairman Robert James Gamgort sold 416,000 shares of the firm’s stock in a transaction that occurred on Tuesday, March 4th. The shares were sold at an average price of $34.29, for a total transaction of $14,264,640.00. Following the sale, the chairman now owns 3,237,066 shares of the company’s stock, valued at approximately $110,998,993.14. This trade represents a 11.39 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Angela A. Stephens sold 7,350 shares of Keurig Dr Pepper stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $34.17, for a total value of $251,149.50. Following the sale, the vice president now owns 74,587 shares in the company, valued at $2,548,637.79. This trade represents a 8.97 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 84,421,350 shares of company stock valued at $2,757,137,010 in the last 90 days. Company insiders own 1.00% of the company’s stock.

Institutional Trading of Keurig Dr Pepper

A number of institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. increased its position in Keurig Dr Pepper by 23.6% during the 4th quarter. Vanguard Group Inc. now owns 119,587,162 shares of the company’s stock worth $3,841,140,000 after purchasing an additional 22,856,757 shares in the last quarter. Price T Rowe Associates Inc. MD raised its stake in Keurig Dr Pepper by 36.0% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 54,656,384 shares of the company’s stock worth $1,755,564,000 after purchasing an additional 14,473,054 shares during the period. Barrow Hanley Mewhinney & Strauss LLC boosted its holdings in Keurig Dr Pepper by 65.0% in the fourth quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 21,219,771 shares of the company’s stock valued at $681,579,000 after acquiring an additional 8,363,192 shares during the last quarter. Norges Bank purchased a new stake in shares of Keurig Dr Pepper during the 4th quarter worth about $197,819,000. Finally, Wellington Management Group LLP grew its stake in Keurig Dr Pepper by 10.3% during the fourth quarter. Wellington Management Group LLP now owns 60,602,781 shares of the company’s stock worth $1,946,561,000 after buying an additional 5,646,179 shares during the period. Hedge funds and other institutional investors own 93.99% of the company’s stock.

About Keurig Dr Pepper

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.